News
12 Health Care Stocks Moving In Wednesday's After-Market Session
13 Mar 24
Movers
Lipocine Announces Confirmation Of Dosing Regimen For Pivotal Study Of LPCN 1154
6 Feb 24
Biotech, News, General
12 Health Care Stocks Moving In Thursday's Pre-Market Session
18 Jan 24
Movers
Lipocine And Verity Pharma Enter Into License Agreement For TLANDO Franchise In The U.S. And Canada; Lipocine To Receive $11M License Fee; Up To $259M In Development And Commercial Sales Milestones
18 Jan 24
Biotech, News, Contracts, Global, General
Press releases
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
7 Mar 24
Earnings, Press Releases
Lipocine to Present at 36th Annual Roth Conference
6 Mar 24
Press Releases
Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals
2 Feb 24
Press Releases
Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada
18 Jan 24
Press Releases